Literature DB >> 2139036

Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin.

R M Lyons1, L E Gentry, A F Purchio, H L Moses.   

Abstract

Medium conditioned by Chinese hamster ovary (CHO) cells transfected with the simian pre-pro-TGF beta 1 cDNA contains high levels of latent TGF beta 1. The amino-terminal region of the TGF beta 1 precursor is secreted and can be detected in the conditioned medium by immunoblotting using peptide antibodies specific for amino-terminal peptides. Chemical cross-linking of CHO-conditioned medium using bis-(sulfosuccinimidyl)-suberate (BS3) followed by immunoblot analyses indicates that latent recombinant TGF beta 1 contains both the cleaved amino-terminal glycopeptide and mature TGF beta 1 polypeptide in a noncovalent association and that this association confers latency. The data presented here do not support the involvement of a unique TGF beta binding protein(s) in latent recombinant TGF beta 1. Plasmin treatment of CHO-conditioned medium resulted in the appearance of TGF beta competing activity. In addition, immunoblot analysis of plasmin-treated CHO-conditioned medium indicates that the amino-terminal glycopeptide is partially degraded and that mature TGF beta 1 is released. Thus, activation of latent TGF beta 1 may occur by proteolytic nicking within the amino-terminal glycopeptide thereby causing a disruption of tertiary structure and noncovalent bonds, which results in the release of active, mature TGF beta 1. Acid activation of latent TGF beta, in comparison, appears to be due to dissociation of the amino-terminal glycopeptide from the mature polypeptide.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139036      PMCID: PMC2116088          DOI: 10.1083/jcb.110.4.1361

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  24 in total

1.  Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions.

Authors:  D A Lawrence; R Pircher; P Jullien
Journal:  Biochem Biophys Res Commun       Date:  1985-12-31       Impact factor: 3.575

2.  Normal embryo fibroblasts release transforming growth factors in a latent form.

Authors:  D A Lawrence; R Pircher; C Krycève-Martinerie; P Jullien
Journal:  J Cell Physiol       Date:  1984-10       Impact factor: 6.384

3.  Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.

Authors:  R F Tucker; E L Branum; G D Shipley; R J Ryan; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

4.  Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells.

Authors:  R Derynck; J A Jarrett; E Y Chen; D H Eaton; J R Bell; R K Assoian; A B Roberts; M B Sporn; D V Goeddel
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

5.  Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts.

Authors:  M Laiho; O Saksela; J Keski-Oja
Journal:  Exp Cell Res       Date:  1986-06       Impact factor: 3.905

6.  Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization.

Authors:  K Miyazono; U Hellman; C Wernstedt; C H Heldin
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

7.  A new prosomatostatin-derived peptide reveals a pattern for prohormone cleavage at monobasic sites.

Authors:  R Benoit; N Ling; F Esch
Journal:  Science       Date:  1987-11-20       Impact factor: 47.728

8.  Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex.

Authors:  R Pircher; P Jullien; D A Lawrence
Journal:  Biochem Biophys Res Commun       Date:  1986-04-14       Impact factor: 3.575

9.  Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta.

Authors:  J Keski-Oja; F Blasi; E B Leof; H L Moses
Journal:  J Cell Biol       Date:  1988-02       Impact factor: 10.539

10.  Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.

Authors:  M Laiho; O Saksela; P A Andreasen; J Keski-Oja
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  171 in total

1.  Platelet-derived growth factor is a principal inductive factormodulating mannose 6-phosphate/insulin-like growth factor-II receptorgene expression via a distal E-box in activated hepatic stellate cells.

Authors:  J A Weiner; A Chen; B H Davis
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

2.  Effect of anti-fibrosis compound on collagen expression of hepatic cells in experimental liver fibrosis of rats.

Authors:  Ling-Tai Wang; Bin Zhang; Jian-Jie Chen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 3.  Latent-TGF-beta: an overview.

Authors:  D A Lawrence
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

4.  Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1.

Authors:  M H Poczatek; C Hugo; V Darley-Usmar; J E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

5.  Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.

Authors:  Q Yu; I Stamenkovic
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

Review 6.  The extracellular regulation of growth factor action.

Authors:  R Flaumenhaft; D B Rifkin
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

7.  Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.

Authors:  Nathalie di Clemente; Soazik P Jamin; Alexey Lugovskoy; Paul Carmillo; Christian Ehrenfels; Jean-Yves Picard; Adrian Whitty; Nathalie Josso; R Blake Pepinsky; Richard L Cate
Journal:  Mol Endocrinol       Date:  2010-09-22

8.  Integrin alpha3beta1 potentiates TGFbeta-mediated induction of MMP-9 in immortalized keratinocytes.

Authors:  John M Lamar; Vandana Iyer; C Michael DiPersio
Journal:  J Invest Dermatol       Date:  2007-08-30       Impact factor: 8.551

9.  Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression.

Authors:  J A Reed; N S McNutt; V G Prieto; A P Albino
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

10.  Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.

Authors:  T Abe; T Mori; K Kohno; M Seiki; T Hayakawa; H G Welgus; S Hori; M Kuwano
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.